Enevolv Inc engineers and licenses microorganisms (i.e., bacteria, yeast, and algae) to produce chemicals, enzymes, and small molecules for variety of industries including specialty chemicals, food, energy, personal care, and pharmaceuticals. enEvolv collaborates with companies to engineer novel microorganisms. Firm also improves existing strains to increase production yield and product quality. By treating the genome as the unit of engineering, enEvolv offers substantial advantage in speed, cost, and cellular engineering capabilities. enEvolvâs proprietary genome engineering platform is built on Multiplex Automated Genome Engineering (MAGE), developed at Harvard by co-founders, George Church and Farren Isaacs
